MacDermott R P, Schmidt R E, Caulfield J P, Hein A, Bartley G T, Ritz J, Schlossman S F, Austen K F, Stevens R L
J Exp Med. 1985 Dec 1;162(6):1771-87. doi: 10.1084/jem.162.6.1771.
A clone of natural killer (NK) cells (JTB18) was found to be ultrastructurally similar to peripheral blood large granular lymphocytes (LGL). These cells incorporated [35S]sulfate into cell-associated proteoglycan molecules, which were then isolated by CsCl density gradient centrifugation. As assessed by gel filtration chromatography, the native 35S-labeled proteoglycan and its beta-eliminated 35S-labeled glycosaminoglycans were of Mr approximately 200,000 and 50,000, respectively. The 35S-labeled proteoglycans were resistant to proteolysis, since their Mr were apparently not altered by incubation with either pronase or S. aureus V8 protease. The purified NK cell 35S-labeled proteoglycans were degraded by approximately 90% to 35S-labeled disaccharides with either chondroitinase ABC or AC. High performance liquid chromatographic analysis of the digests revealed these disaccharides to be composed entirely of chondroitin sulfate A (glucuronic acid----N-acetylgalactosamine-4SO4). Whole 35S-labeled cells incubated with chondroitinase ABC failed to release 35S-labeled disaccharides into the supernatant, and x-ray energy-dispersive analysis revealed that sulfur-containing molecules were present in the intracellular granules, thereby localizing the NK cell-associated proteoglycan primarily in the granules of the cell, rather than on the plasma membrane. The 35S-labeled cloned NK cells incubated for 30 min to 4 h with K562 tumor cell targets at a 0.5:1 ratio exocytosed a mean of 49% of the granular 35S-labeled proteoglycans during the first 60 min of the culture. Proteoglycan release was maximal with an effector/target cell ratio of 0.5:1 for JTB18:K562. Significant proteoglycan release from JTB18 NK cells was also obtained with other sensitive target cells such as REX, Molt4, and CEM, but not with cells such as KG1 and Laz156, which have been shown previously to be resistant to killing by this NK cell. Thus, protease-resistant intracellular proteoglycans with chondroitin sulfate A side chains are specifically exocytosed from the granules of human NK effector cells upon contact with sensitive targets, suggesting that these proteoglycans may be involved in the mechanism of cytotoxicity.
发现一种自然杀伤(NK)细胞克隆(JTB18)在超微结构上与外周血大颗粒淋巴细胞(LGL)相似。这些细胞将[35S]硫酸盐掺入细胞相关蛋白聚糖分子中,然后通过氯化铯密度梯度离心法进行分离。通过凝胶过滤色谱法评估,天然的35S标记蛋白聚糖及其β-消除的35S标记糖胺聚糖的分子量分别约为200,000和50,000。35S标记的蛋白聚糖对蛋白水解具有抗性,因为用链霉蛋白酶或金黄色葡萄球菌V8蛋白酶孵育后其分子量显然没有改变。纯化的NK细胞35S标记蛋白聚糖用软骨素酶ABC或AC处理后可降解约90%成为35S标记的二糖。对消化产物进行高效液相色谱分析表明,这些二糖完全由硫酸软骨素A(葡萄糖醛酸----N-乙酰半乳糖胺-4SO4)组成。用软骨素酶ABC孵育的完整35S标记细胞未能将35S标记的二糖释放到上清液中,并且X射线能量色散分析表明细胞内颗粒中存在含硫分子,从而将NK细胞相关蛋白聚糖主要定位在细胞的颗粒中,而不是在质膜上。以0.5:1的比例将35S标记的克隆NK细胞与K562肿瘤细胞靶标孵育30分钟至4小时,在培养的前60分钟内,平均有49%的颗粒状35S标记蛋白聚糖胞吐。对于JTB18:K562,效应细胞/靶细胞比例为0.5:1时蛋白聚糖释放最大。用其他敏感靶细胞如REX、Molt4和CEM也可从JTB18 NK细胞中获得显著的蛋白聚糖释放,但用如KG1和Laz156等细胞则不能,先前已证明这些细胞对这种NK细胞的杀伤具有抗性。因此,具有硫酸软骨素A侧链的抗蛋白酶细胞内蛋白聚糖在与敏感靶标接触时会从人NK效应细胞的颗粒中特异性地胞吐,这表明这些蛋白聚糖可能参与细胞毒性机制。